Clinical competencies in allergy and immunology: Results of a graduate survey
James T. Li+3 more
openalex +1 more source
Contribution to Enrichment of Korean Academy of Asthma Allergy Clinical Immunology: Homage to Professor You-Young Kim, the Pioneer Exploring Allergology in Korea [PDF]
Sang‐Heon Cho
openalex +1 more source
Integrating innovation and shared decision-making in allergy and immunology practice. [PDF]
Bellanti JA, Settipane RA.
europepmc +1 more source
Allergic rhinitis management: a Delphi Consensus promoted by the Italian Society of Pediatric Allergy and Immunology (SIAIP). [PDF]
Miraglia Del Giudice M+5 more
europepmc +1 more source
Testing of IgG and IgG4 to foods is not recommended / Position of the German Society of Allergy and Clinical Immunology (DGAKI) a , the Physician's Society of German Allergists (ÄDA) and the Society of Pediatric Allergy and Environmental Medicine (GPA), the Austrian Society of Allergy and Immunology (ÖGAI) and the Swiss Society of Allergy and Immunology (SGAI) after Adoption of the Task Force Report b of the European Academy of Allergy and Clinical Immunology (EAACI) [PDF]
Jörg Kleine‐Tebbe+19 more
openalex +1 more source
Scientometric Data and Open Access Publication Policies of Clinical Allergy and Immunology Journals. [PDF]
Tazegul G, Emre E.
europepmc +1 more source
Knowledge of teachers concerning food allergies in the primary schools of Edirne city and school facilities for emergent treatment. This study was presented at XVII National Allergy And Clinical Immunology Congress Of Turkey, 3-7 December 2009 Antalya/Turkey [PDF]
Mehtap Yazýcýoðlu+6 more
openalex +1 more source
Knowledge about occupational latex allergy amongst Thai nurses and student nurses. [PDF]
De Vocht, Frank+2 more
core +1 more source
ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler+6 more
wiley +1 more source